Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endocrine-related Adverse Events Caused by Immune Checkpoint Inhibitors

NCT05675111 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT05675111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05675111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endocrine-related Adverse Events Caused by Immune Checkpoint Inhibitors
Lead sponsor
Nanjing Medical University
Phase
Observational
Overall status
Completed
Start date
June 1, 2018
Completion date
October 30, 2022
Enrollment
12,408 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endocrine toxicity, immune checkpoint inhibitor